New combo therapy aims to stop liver cancer in its tracks
NCT ID NCT04996914
First seen May 12, 2026 · Last updated May 13, 2026 · Updated 1 time
Summary
This study tests whether adding targeted radiation therapy after a standard liver cancer procedure (TACE) can better control tumors in people with early or intermediate-stage liver cancer who cannot have surgery. About 30 adults aged 18-80 with 1-3 tumors (at least 4 cm total) will receive the combination treatment. The main goal is to see if the treated tumors stay under control for at least one year.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA NON-RESECTABLE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
RWTH Aachen University Hospital
RECRUITINGAachen, North Rhine-Westphalia, 52074, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.